Journal ArticleJournal of Cardiac Failure · October 1, 2024
Introduction: Little is known about the use of cangrelor in patients with myocardial infarction (MI) presenting with cardiogenic shock (CS). Methods: CAMEO (Cangrelor in Acute MI: Effectiveness and Outcomes) is a multicenter observational registry evaluati ...
Full textCite
Journal ArticleJournal of Cardiac Failure · October 1, 2024
Patients with heart failure (HF) and underlying coronary artery disease (CAD) have a substantially higher risk of mortality compared with those with HF from other causes. However, identifying individuals with HF for whom revascularization is likely to impr ...
Full textCite
Journal ArticleJAMA Cardiol · September 1, 2024
IMPORTANCE: Pragmatic randomized clinical trials (RCTs) often use multiple data sources to examine clinical events, but the relative contribution of data sources to clinical end-point rates is understudied. OBJECTIVE: To assess the contribution of data sou ...
Full textLink to itemCite
Journal ArticleJACC Adv · August 2024
BACKGROUND: Elevated interleukin (IL)-6 levels have been linked to adverse outcomes in patients with and without baseline cardiovascular disease (CVD). OBJECTIVES: The purpose of this study was to examine the association between circulating IL-6 levels and ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 21, 2024
BACKGROUND: Little is known about the procedural characteristics, case volumes, and mortality rates for early- vs non-early-career interventional cardiologists in the United States. OBJECTIVES: This study examined operator-level data for patients who under ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · May 1, 2024
IMPORTANCE: Currently, mortality risk for patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with an uncomplicated postprocedure course is low. Less is known regarding the risk of ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · April 22, 2024
Aging is the gradual decline in physical and physiological functioning leading to increased susceptibility to stressors and chronic illnesses, including cardiovascular disease. With an aging global population, in which 1 in 6 individuals will be older than ...
Full textLink to itemCite
ConferenceJ Soc Cardiovasc Angiogr Interv · February 2024
BACKGROUND: Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y12 inhibitor before coronary angiography. METHODS: Cangrelor in Acute MI: Effectiveness and Outcomes ...
Full textLink to itemCite
Journal ArticleJ Soc Cardiovasc Angiogr Interv · February 2024
BACKGROUND: Calcified coronary lesions are a challenge for percutaneous coronary interventions (PCIs). Coronary intravascular lithotripsy (IVL) is a novel calcium modification technology approved for commercial use in February 2021, but little is known abo ...
Full textLink to itemCite
Journal ArticleJournal of the Society for Cardiovascular Angiography and Interventions · February 1, 2024
The prevalence of calcification in obstructive coronary artery disease is on the rise. Percutaneous coronary intervention of these calcified lesions is associated with increased short-term and long-term risks. To optimize percutaneous coronary intervention ...
Full textCite
Journal ArticleCardiovascular Revascularization Medicine · January 1, 2024
In 2020, the NIH and FDA issued guidance documents that laid the foundation for human subject research during an unprecedented pandemic. To bridge these general considerations to actual applications in cardiovascular interventional device trials, the PAnde ...
Full textCite
ConferenceCirculation · December 12, 2023
BACKGROUND: Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgi ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · September 25, 2023
BACKGROUND: Acute kidney injury (AKI) is the most common complication after percutaneous coronary intervention (PCI). Accurately estimating patients' risks not only creates a means of benchmarking performance but can also be used prospectively to inform pr ...
Full textLink to itemCite
Journal ArticleJournal of Cardiac Failure · October 1, 2024
Introduction: Little is known about the use of cangrelor in patients with myocardial infarction (MI) presenting with cardiogenic shock (CS). Methods: CAMEO (Cangrelor in Acute MI: Effectiveness and Outcomes) is a multicenter observational registry evaluati ...
Full textCite
Journal ArticleJournal of Cardiac Failure · October 1, 2024
Patients with heart failure (HF) and underlying coronary artery disease (CAD) have a substantially higher risk of mortality compared with those with HF from other causes. However, identifying individuals with HF for whom revascularization is likely to impr ...
Full textCite
Journal ArticleJAMA Cardiol · September 1, 2024
IMPORTANCE: Pragmatic randomized clinical trials (RCTs) often use multiple data sources to examine clinical events, but the relative contribution of data sources to clinical end-point rates is understudied. OBJECTIVE: To assess the contribution of data sou ...
Full textLink to itemCite
Journal ArticleJACC Adv · August 2024
BACKGROUND: Elevated interleukin (IL)-6 levels have been linked to adverse outcomes in patients with and without baseline cardiovascular disease (CVD). OBJECTIVES: The purpose of this study was to examine the association between circulating IL-6 levels and ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 21, 2024
BACKGROUND: Little is known about the procedural characteristics, case volumes, and mortality rates for early- vs non-early-career interventional cardiologists in the United States. OBJECTIVES: This study examined operator-level data for patients who under ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · May 1, 2024
IMPORTANCE: Currently, mortality risk for patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with an uncomplicated postprocedure course is low. Less is known regarding the risk of ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · April 22, 2024
Aging is the gradual decline in physical and physiological functioning leading to increased susceptibility to stressors and chronic illnesses, including cardiovascular disease. With an aging global population, in which 1 in 6 individuals will be older than ...
Full textLink to itemCite
ConferenceJ Soc Cardiovasc Angiogr Interv · February 2024
BACKGROUND: Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y12 inhibitor before coronary angiography. METHODS: Cangrelor in Acute MI: Effectiveness and Outcomes ...
Full textLink to itemCite
Journal ArticleJ Soc Cardiovasc Angiogr Interv · February 2024
BACKGROUND: Calcified coronary lesions are a challenge for percutaneous coronary interventions (PCIs). Coronary intravascular lithotripsy (IVL) is a novel calcium modification technology approved for commercial use in February 2021, but little is known abo ...
Full textLink to itemCite
Journal ArticleJournal of the Society for Cardiovascular Angiography and Interventions · February 1, 2024
The prevalence of calcification in obstructive coronary artery disease is on the rise. Percutaneous coronary intervention of these calcified lesions is associated with increased short-term and long-term risks. To optimize percutaneous coronary intervention ...
Full textCite
Journal ArticleCardiovascular Revascularization Medicine · January 1, 2024
In 2020, the NIH and FDA issued guidance documents that laid the foundation for human subject research during an unprecedented pandemic. To bridge these general considerations to actual applications in cardiovascular interventional device trials, the PAnde ...
Full textCite
ConferenceCirculation · December 12, 2023
BACKGROUND: Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgi ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · September 25, 2023
BACKGROUND: Acute kidney injury (AKI) is the most common complication after percutaneous coronary intervention (PCI). Accurately estimating patients' risks not only creates a means of benchmarking performance but can also be used prospectively to inform pr ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · September 25, 2023
BACKGROUND: The prediction of mortality, bleeding, and acute kidney injury (AKI) after percutaneous coronary intervention (PCI) traditionally relied on race-based estimates of the glomerular filtration rate (GFR). Recently, race agnostic equations were dev ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · August 25, 2023
Spontaneous coronary artery dissection (SCAD) is a rare but important nonatherosclerotic cause of acute coronary syndrome. Indications for revascularization and long-term outcomes of SCAD remain areas of active investigation. We report our experience with ...
Full textLink to itemCite
Journal ArticleJACC Adv · July 2023
We review a comprehensive risk assessment approach for percutaneous coronary interventions in older adults and highlight the relevance of geriatric syndromes within that broader perspective to optimize patient-centered outcomes in interventional cardiology ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · June 20, 2023
Background Premature discontinuation of P2Y12 inhibitor therapy has been associated with adverse cardiac events, which might be preventable by improving medication persistence. Current risk models have limited ability to predict patients at risk of P2Y12 i ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2023
BACKGROUND: Limited data exists regarding the relationships between resource use and outcomes in patients with mitral regurgitation (MR). We examined resource utilization and outcomes across MR type and severity. METHODS: Using the Duke Echocardiography La ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · June 1, 2023
IMPORTANCE: Although reduced doses of direct oral anticoagulants (DOACs) are approved for patients with nonvalvular atrial fibrillation (NVAF) at high risk of bleeding, little is known about dosing accuracy, particularly in patients with renal dysfunction. ...
Full textLink to itemCite
Journal ArticleJACC Adv · June 2023
As the population ages, older adults represent an increasing proportion of patients referred to the cardiac catheterization laboratory. Older adults are the highest-risk group for morbidity and mortality, particularly after complex, high-risk percutaneous ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Imaging · May 2023
BACKGROUND: The relationship between body size and cardiovascular events is complex. This study utilized the ADVANCE (Assessing Diagnostic Value of Noninvasive FFRCT in Coronary Care) Registry to investigate the association between body mass index (BMI), c ...
Full textLink to itemCite
Journal ArticleJ Soc Cardiovasc Angiogr Interv · 2023
Stent failure remains the major drawback to the use of coronary stents as a revascularization strategy. Recent advances in imaging have substantially improved our understanding of the mechanisms underlying these occurrences, which have in common numerous c ...
Full textLink to itemCite
Journal ArticleCirculation · December 6, 2022
BACKGROUND: There are no randomized data evaluating the safety or efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial fibrillation (AF). METHODS: The RENAL-AF trial (Renal Hemodialysis Patien ...
Full textLink to itemCite
Journal ArticleCardiovasc Revasc Med · December 2022
INTRODUCTION: The COVID-19 pandemic had an unprecedented impact on cardiovascular clinical research. The decision-making and state of study operations in cardiovascular trials 1-year after interruption has not been previously described. METHODS: In the spr ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · October 18, 2022
Background Persistence to P2Y12 inhibitors after myocardial infarction (MI) remains low. Out-of-pocket cost is cited as a factor affecting medication compliance. We examined whether a copayment intervention affected 1-year persistence to P2Y12 inhibitors a ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · October 2022
PURPOSE OF REVIEW: Women are less often recognized to have cardiovascular disease (CVD) risk and are underrepresented in randomized trials of lipid-lowering therapy. Here, we summarize non-pharmacologic and pharmacologic strategies for lipid-lowering in wo ...
Full textLink to itemCite
Journal ArticleVasc Med · August 2022
BACKGROUND: Peripheral artery disease (PAD) is associated with modifiable atherosclerotic risk factors like hypertension, diabetes, hyperlipidemia, and smoking. However, the effect of risk factor control on outcomes and disparities in achieving control is ...
Full textLink to itemCite
Journal ArticleJournal of the Society for Cardiovascular Angiography and Interventions · July 1, 2022
Evidence-based recommendations for clinical practice are intended to help health care providers and patients make decisions, minimize inappropriate practice variation, promote effective resource use, improve clinical outcomes, and direct future research. S ...
Full textCite
Journal ArticleJ Am Heart Assoc · June 7, 2022
Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention-related ischemic complications without increasing major bleeding. This study was performed to examine cangrelor use and transition to oral P2Y12 inhibitors ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · January 2022
BACKGROUND: Due to increased risks of contrast nephropathy, chronic kidney disease (CKD) can deter consideration of invasive management for patients with myocardial infarction (MI). Black patients have a higher prevalence of CKD. Whether racial disparities ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · January 2022
Patient-reported outcome measures (PROMs) are health outcomes directly reported by the patient that can be used to measure the effect of disease and treatments on patient perceived well-being. This review summarizes current evidence regarding the validatio ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · October 12, 2021
Patients undergoing early surgery after coronary stent implantation are at increased risk for mortality from ischemic and hemorrhagic complications. The optimal antiplatelet strategy in patients who cannot discontinue dual antiplatelet therapy (DAPT) befor ...
Full textLink to itemCite
Journal ArticleCardiooncology · June 21, 2021
Increasing evidence suggests a multifaceted relationship exists between cancer and cardiovascular disease (CVD). Here, we introduce a 5-tier classification system to categorize cardio-oncology syndromes (COS) that represent the aspects of the relationship ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · June 2021
Background Direct oral anticoagulants (DOACs) are effective in reducing the stroke risk for patients with nonvalvular atrial fibrillation if prescribed at the labeled dose, yet underdosing is frequent. Little is known about clinician knowledge and patient ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · April 26, 2021
OBJECTIVES: The aims of this study were to examine rates of radial artery access in post-coronary artery bypass grafting (CABG) patients undergoing diagnostic catherization and/or percutaneous coronary intervention (PCI), whether operators with higher proc ...
Full textLink to itemCite
Journal ArticleVasc Endovascular Surg · February 2021
PURPOSE: Patients with diabetes mellitus (DM) are known to be at higher risk for peripheral artery disease (PAD), amputations, and major adverse cardiovascular events, though it is unclear whether they are at any higher risk for repeat intervention. LIBERT ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · January 22, 2021
PURPOSE OF REVIEW: There is a lack of consistency among the ACC/AHA and ESC Guidelines on the treatment of patients with lower extremity PAD to a targeted LDL-c level. A review of the current guidelines, as well as the evidence that exists for use of vario ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · January 5, 2021
Background Evidence-based medication adherence rates after a myocardial infarction are low. We hypothesized that 90-day prescriptions are underused and may lead to higher evidence-based medication adherence compared with 30-day fills. Methods and Results W ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · January 4, 2021
IMPORTANCE: The proportion of women and underrepresented racial and ethnic groups (UREGs) matriculating into general cardiology fellowships remains low. OBJECTIVE: To assess a systematic recruitment initiative aimed at ensuring adequate matriculation of wo ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · January 1, 2021
The purpose of this analysis was to assess implantable cardioverter-defibrillator (ICD) utilization and its association with mortality among patients ≥65 years of age after coronary revascularization. Patients in the National Cardiovascular Database Regist ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · December 2020
BACKGROUND: Randomized clinical trials have demonstrated that catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction may improve survival and other cardiovascular outcomes. METHODS: We constructed a decision ...
Full textLink to itemCite
Journal ArticleClin Cardiol · November 2020
BACKGROUND: Patients with chronic kidney disease (CKD) have worsened clinical outcomes following percutaneous coronary intervention; however, limited evidence exists in patients undergoing peripheral vascular intervention (PVI). PURPOSE: We aimed to assess ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · October 20, 2020
Background There are limited data on health status instruments in patients with peripheral artery disease and cardiovascular and limb events. We evaluated the relationship between health status changes and cardiovascular and limb events. Methods and Result ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · October 2020
BACKGROUND: Patients with peripheral artery disease have a high risk of future cardiovascular disease events and mortality. Little is known about the changes in symptom classification over time in patients with peripheral artery disease and the association ...
Full textLink to itemCite
Journal ArticleAm Heart J · June 2020
BACKGROUND: Patients with bicuspid aortic valve stenosis (BAV) were excluded from all the trileaflet aortic valve stenosis (TAV) pivotal trials, and therefore, their outcomes are not clearly defined. The aim of the study was to evaluate the outcomes of tra ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · May 5, 2020
Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are used to reduce low-density lipoprotein (LDL) cholesterol. PCSK9i use after initiation, as well as persistence with or alterations to other LDL-lowering therapy after PCSK9i in ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · April 2020
BACKGROUND: Palliative care improves quality of life in patients with heart failure. Whether men and women with heart failure derive similar benefit from palliative care interventions remains unknown. METHODS: In a secondary analysis of the PAL-HF trial (P ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 17, 2019
BACKGROUND: Transcatheter mitral valve repair (TMVr) for the treatment of mitral regurgitation (MR) is a complex procedure that requires development of a unique skillset. OBJECTIVES: The purpose of this study was to examine the relationship between operato ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · December 9, 2019
OBJECTIVES: The aim of this study was to assess the real-world impact of transcatheter mitral valve repair (TMVR) on hospitalizations and Medicare costs pre- versus post-TMVR. BACKGROUND: TMVR is effective in degenerative mitral regurgitation (MR) and appr ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2019
Advanced age is directly related to worse outcomes following ST-elevation myocardial infarction (STEMI) and higher complication rates from antithrombotic therapies and primary percutaneous coronary intervention (PCI). Often excluded from clinical trials, s ...
Full textLink to itemCite
Journal ArticleAm Heart J · December 2019
BACKGROUND: Available data suggest that same-day discharge (SDD) after elective percutaneous coronary intervention (PCI) is safe in select patients. Yet, little is known about contemporary adoption rates, safety, and costs in a universal health care system ...
Full textLink to itemCite
Journal ArticleAm Heart J · October 2019
UNLABELLED: Percutaneous coronary intervention (PCI) may be performed in the same procedure as diagnostic coronary angiography (ad hoc PCI). This study aimed to evaluate current rates of ad hoc PCI use and associated risks of adverse outcomes in patients w ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · October 2019
Background When patients require readmission after a recent myocardial infarction (MI), returning to the discharging (index) hospital may be associated with better outcomes as a result of greater continuity in care. However, little evidence exists to answe ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · September 23, 2019
OBJECTIVES: This study sought to evaluate the outcomes and factors associated with aborted procedures among patients undergoing elective transcatheter aortic valve replacement (TAVR). BACKGROUND: Elective TAVR procedures can be aborted because of device li ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 15, 2019
Fragmented care following elective surgery has been associated with poor outcomes. The association between fragmented care and outcomes in patients undergoing transcatheter aortic valve implantation (TAVI) is unknown. We examined patients who underwent TAV ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · July 22, 2019
OBJECTIVES: The aim of this study was to examine the relation between institutional experience and procedural results of transcatheter mitral valve repair. BACKGROUND: Transcatheter mitral valve repair for the treatment of mitral regurgitation (MR) is a co ...
Full textLink to itemCite
Journal ArticleJ Invasive Cardiol · July 2019
BACKGROUND: Alternative access (AA) is still required for a significant proportion of patients undergoing transcatheter aortic valve replacement (TAVR). We sought to compare the clinical outcomes of patients undergoing AA vs transfemoral (TF) access. METHO ...
Link to itemCite
Journal ArticleJ Am Heart Assoc · May 21, 2019
Background Although recommended in the guidelines, the safety of chronic P2Y12 inhibitor therapy in patients with chronic kidney disease ( CKD ) after an acute myocardial infarction ( MI ) is not well studied. Methods and Results The TRANSLATE -ACS (Treatm ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · May 2019
BACKGROUND: SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women), a randomized controlled trial comparing radial and femoral access in women undergoing cardiac catheterization or percutaneous coronary intervention (PCI), was terminate ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · March 12, 2019
High-sensitivity cardiac troponin (hs-cTn) I or T methods have been in use in certain regions for years but are now increasingly globally adopted, including in the United States. Accordingly, inevitable challenges are created for institutions transitioning ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · March 1, 2019
The introduction of transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of patients with severe aortic stenosis (AS). However, despite the great clinical success of TAVI, less is known about the cardiac hemodynamics and structur ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 4, 2018
BACKGROUND: Prosthesis-patient mismatch (PPM) after surgical aortic valve replacement (AVR) for aortic stenosis is generally associated with worse outcomes. Transcatheter AVR (TAVR) can achieve a larger valve orifice and the effects of PPM after TAVR are l ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · September 4, 2018
Background Physician shortages and reimbursement changes have led to greater use of advanced practice providers ( APP s). Prevalence of and outcomes associated with APP care following myocardial infarction are unknown. Methods and Results We examined outpa ...
Full textLink to itemCite
Journal ArticleAm Heart J · July 2018
BACKGROUND: Length of stay after non-ST-segment elevation myocardial infarction (NSTEMI) continues to decrease, but information to guide duration of hospitalization is limited. METHODS: We used landmark analyses, in which the landmark defined potential day ...
Full textLink to itemCite
Journal ArticleAm Heart J · April 2018
BACKGROUND: Low health literacy is common in the United States and may affect outcomes after myocardial infarction (MI). How often hospitals screen for low health literacy is unknown. METHODS: We surveyed 122 hospitals in the TRANSLATE-ACS study and divide ...
Full textLink to itemCite
Journal ArticleCoron Artery Dis · March 2018
The mechanisms, pathophysiology, and treatment of anemia in coronary artery disease (CAD) are complex. The hemodynamic changes found in the acute anemic state may contribute to progressive arterial wall and left ventricular hypertrophy if the anemic state ...
Full textLink to itemCite
Journal ArticleJACC Basic Transl Sci · August 2017
The importance of inflammation and inflammatory pathways in atherosclerotic disease and acute coronary syndromes (ACS) is well established. The success of statin therapy rests not only on potently reducing levels of low-density lipoprotein cholesterol, but ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · October 1, 2016
In 2006, the United States (US) Food and Drug Administration published advisory highlighting concerns for late drug-eluting stent thrombosis; its impact on US bare-metal stent (BMS) utilization is unknown. We examined rates of BMS use among Medicare patien ...
Full textLink to itemCite
Journal ArticleJAMA · November 10, 2015
IMPORTANCE: About 10% of patients with acute chest pain are ultimately diagnosed with acute coronary syndrome (ACS). Early, accurate estimation of the probability of ACS in these patients using the clinical examination could prevent many hospital admission ...
Full textLink to itemCite
Journal ArticleAm Heart J · January 2015
BACKGROUND: There is no universally accepted algorithm for identifying atrial fibrillation (AF) patients and stroke risk using electronic data for use in performance measures. METHODS: Patients with AF seen in clinic were identified based on International ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · November 15, 2014
There is increasing emphasis on optimizing evidence-based medication (EBM) persistence as a means to improve longitudinal patient outcomes after acute myocardial infarction (MI); yet it is unknown whether differences in medication persistence exist between ...
Full textLink to itemCite
Journal ArticleAm J Gastroenterol · June 2013
OBJECTIVES: Extraesophageal symptoms are common manifestations of gastroesophageal reflux disease (GERD). Lack of a definitive diagnostic or treatment standards complicate management, which often leads to multiple specialty consultations, procedures, pharm ...
Full textLink to itemCite
Journal ArticleCase Rep Cardiol · 2013
A 54-year-old African American male with no medical history presented to an urgent care clinic with signs and symptoms of new-onset congestive heart failure. There was an initial concern for congestive heart failure secondary to an ischemic etiology as an ...
Full textLink to itemCite
Journal ArticleClin Gastroenterol Hepatol · October 2011
BACKGROUND & AIMS: Symptom index (SI) and symptom association probability (SAP) are indexes used to analyze data collected from ambulatory pH and/or impedance monitoring and quantify the association between symptoms and reflux events. However, their charac ...
Full textLink to itemCite
Journal ArticleMed Teach · 2010
BACKGROUND: Medical students have unmet needs in the areas of career and wellness advising. AIMS: The goal of this study is to describe the development of an Advisory College Program (ACP) and assess its effectiveness compared to a traditional one-on-one f ...
Full textLink to itemCite
ConferenceJ Am Coll Surg · May 2009
BACKGROUND: The role of adjuvant chemoradiation therapy (CRT) in pancreatic cancer remains controversial. The primary aim of this study was to determine if CRT improved survival in patients with resected pancreatic cancer in a large, multiinstitutional coh ...
Full textLink to itemCite
ConferenceAnn Surg · September 2008
OBJECTIVES: To compare perioperative outcomes of laparoscopic left-sided pancreatectomy (LLP) with traditional open left-sided pancreatectomy (OLP) in a multicenter experience. SUMMARY AND BACKGROUND DATA: LLP is being performed more commonly with limited ...
Full textLink to itemCite
Journal ArticleJ Biol Rhythms · February 2007
Mating behavior of small populations of virgin males and females of the cockroach Leucophaea maderae were continuously monitored via time-lapse video recording in controlled laboratory conditions. The time of onset of copulation was found to be rhythmic in ...
Full textLink to itemCite